Growth and Development clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Growth and Development of Pediatric Patients From CRAD001M2301
Sorry, in progress, not accepting new patients
The primary objective of CRAD001M2305 is to report the long-term effects of everolimus treatment on height, weight and sexual development (using Tanner Stages) in children and adolescents with Tuberous Sclerosis Complex (TSC)-associated with Subependymal Giant Cell Astrocytoma (SEGA). The study will monitor the growth and development of pediatric patients with TSC-associated SEGA, previously enrolled in CRAD001M2301 until they reach Tanner Stage V, or until age 16 for females or 17 for males whichever occurs first.
at UCLA
Last updated: